Dr. Alicia Zhou is Color's chief science officer and leads Color's scientific affairs, medical affairs and medical operations teams. She received her Ph.D. from Harvard with a specific focus on cancer biology where her research spanned work at both the Dana-Farber Cancer Institute and the Broad Institute of M.I.T. and Harvard. She subsequently performed her postdoctoral work at UCSF. Dr. Zhou is a co-PI for the NIH's All of Us Research Program Genetic Counseling Resource. At Color, she is responsible for driving Color's scientific and research strategy, as well as managing the operations for Color's medical group, and clinical services teams.

Dr. Arif Kamal serves as chief patient officer at the American Cancer Society. In this role, Dr. Kamal drives coordinated efforts to accelerate progress against cancer through the organization's patient-, caregiver-, and healthcare professional-facing activities. He leads the American Cancer Society's patient support objectives and the development of strategic plans to measurably improve the lives of people with cancer and their families. Dr. Kamal oversees the organization's cancer support, patient navigation, educational programs, patient lodging solutions, Transportation services, contact center, and digital patient support offerings, as well as all aspects of organizational functions that touch cancer patients across 5,000 communities around the globe. Prior to joining the American Cancer Society, Dr. Kamal served for more than 12 years as an oncologist, researcher, and innovative leader at Duke University and the Duke Cancer Institute. He is an Associate Professor of Medicine and Population Health at the Duke University School of Medicine, and recently served as physician quality and outcomes officer at the Duke Cancer Institute.